ABSTRACT
This article aims to assess the highly potent antimicrobial hydrogels composed of cellulose and Arabic gum containing sulfadiazine drug (sulfadiazine-loaded Cel/AG) as drug-targeting carriers. ATR-IR, SEM/ EDS, XRD, and XPS methods were used to investigate the hydrogel. The highest water absorption % was 489.93 ± 4.5 at pH 7.4. Pseudo-second order and Fickian diffusion govern the swelling behavior. The maximal sulfadiazine loading percent was 82.291 ± 74. The in-vitro drug release exhibited significant responses in physiologically simulated pH values. The maximum cumulative release percent was 66.42 ± 0.6 % at pH 7.4. The drug release is predicted by the first order and Korsmeyer-Peppas models. The first diffusion coefficient was (Di = 9.207 ± 47 × 10-3 cm2/h) and the late one was (DL = 5.64 ± 9.0 × 10-2 cm2/h) at pH 7.4. That hydrogel is well-thought-out a potential drug delivery vehicle. The thermal stability of the Cel/AG hydrogel drug carrier has been enhanced by the incorporation of sulfadiazine which is evidenced by increasing the total activation approximately two-fold. The total activation energy of Cel/AG and sulfadiazine-loaded Cel/AG hydrogels were -0.07362 and -0.2092 J/mol. The sulfadiazine medication's inhibitory effect was markedly enhanced when it was incorporated into the Cel/AG hydrogel films.
Subject(s)
Anti-Infective Agents , Hydrogels , Cellulose , Drug Delivery Systems , Anti-Infective Agents/pharmacology , Drug Carriers , Excipients , Sulfadiazine , Drug Liberation , Hydrogen-Ion ConcentrationABSTRACT
In this study, we report the development of physically cross-linked hydroxyethyl cellulose grafted polyacrylic acid-co-polyacrylamide/silver nanocomposite [Ag@HEC-g-P(AA-co-AM)-Fe3+] possesses excellent antimicrobial and enhanced MB adsorption. A green in-situ reduction process was used to prepare silver nanoparticles. UV-Vis spectroscopy, TEM, ATR-IR, XRD, SEM-EDS were used to analyze the green produced silver nanoparticles and Ag@HEC-g-P(AA-co-AM)-Fe3+. The swelling ratio of Ag@HEC-g-P(AA-co-AM)-Fe3+ is dependent on AgNPs content and pH. The swelling kinetics fitted with Pseudo-second order. The cumulative release#% of AgNPs was 29.63 ± 1.7%, respectively up to 10 h and its kinetics obey Korsmeyer-Peppas model. The grafting to HEC and incorporation of AgNPs into HEC-g-P(AA-co-AM)-Fe3+ enhances the thermal stabilities and increases total activation energies from 19,122.2 to 66,287.1 KJ mol. Ag@HEC-g-P(AA-co-AM)-Fe3+ has powerful antimicrobial activity against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis, Micrococcus leutus, Staphyllococus aureus. The maximum adsorption capacity of MB was 133.38 ± 1.25 mg/g at nanocomposite concentration (300 mg/L), pH (9.0), and MB concentration (5 mg/L). To anticipate the adsorption mechanism, Pseudo-first and second-order models, as well as three isotherm models (Langmuir, Freundlich, and Temkin) were used to model adsorption kinetics. The nonlinear Langmuir models and second-order kinetics were the most appropriate.
Subject(s)
Acrylamides/chemistry , Cellulose/analogs & derivatives , Iron , Metal Nanoparticles/chemistry , Methylene Blue/chemistry , Silver , Adsorption , Cellulose/chemistry , Chemical Phenomena , Spectrum Analysis , Thermogravimetry , Water PurificationABSTRACT
Purpose: This study aimed to evaluate the biological and mechanical properties of the poly(methyl methacrylate) (PMMA) denture base material as a vehicle incorporating novel hydroxyapatite nanoparticles (HA-NP) loaded with metronidazole (MZ) drug. Methods: HA-NP was prepared via wet-chemical-method, characterized by XRD, SEM/EDX, TEM, Fourier-transform infrared spectroscopy (FTIR), as well as the measurement of surface area and pore-size distribution. Four drug delivery formulas were prepared in the form of discs (10 x 2 mm) as follows: F1 (MZ/ HA-NP/PMMA), F2 (HA-NP/ PMMA), F3 (control-PMMA) and F4 (MZ/PMMA). Characterization of all formulas was performed using differential scanning calorimetry (DSC) and FTIR. MZ release rate, antimicrobial properties against three oral pathogens, cytotoxicity (MTT assay) and surface micro-hardness were also assessed. Statistical analysis of data was performed using one-way ANOVA test (P < 0.05). Results: DSC thermograms showed compatibility among MZ, HA-NP and PMMA along with physical stability over 6 months storage period at room temperature. FTIR spectroscopy proved the absence of any possible chemical interaction with MZ. MZ-HA-NP/PMMA formula showed relatively better drug release compared to MZ-PMMA. Both formulas showed statistically significant antimicrobial potentials against two microbial strains. MTT demonstrated reduction in cell cytotoxicity after 96 hours with the least value for HA-NP. Surface micro-hardness revealed non-significant reduction compared with the control PMMA. Conclusion: A novel biocompatible drug nanocarrier (HA-NP) was developed and incorporated in PMMA denture base material as a vehicle to allow prolonged sustained drug release to manage oral infections.